Finjan Holdings Continues to Seek Relief from Unauthorized Users of its Patented Technology

Finjan Holdings (NASDAQ:FNJN), a cybersecurity company, has provided the following update for two pending litigations: Finjan v. Blue Coat Systems, LLC, Case No. 15-cv-03295-BLF (“the Blue Coat matter”), and Finjan v. Sophos, Cast No. 3:14-cv-01197-WHO (“the Sophos matter”).
As quoted in the press release:

In the Blue Coat matter, on November 22, 2016 the Honorable Beth Labson-Freeman denied Finjan’s Motion for Preliminary Injunction, finding that although “Finjan is likely to succeed in showing that [US Pat. No. 8,677,494 (“the ‘494 Patent”)] is valid and infringed [by Blue Coat],” Finjan did not overcome the additional heightened requirements for injunctions set forth in current case law, of irreparable harm or that the balance of hardships weighed in its favor.
“While Finjan believes we presented sufficient evidence to support a preliminary injunction against Blue Coat, given the high bar for securing an injunction, we respect the Court’s decision but are not deterred,” said Julie Mar-Spinola, Finjan Holding’s CIPO. “Equally, we are encouraged by Judge Freeman’s analysis on the validity and infringement of the ‘494 Patent by Blue Coat, which is consistent with the recent validity finding of the ‘494 Patent by the jury in the Sophos matter. Finjan will continue to pursue appropriate relief from unlicensed users of our technology.”

Click here for the full text release.